KELLOKUMPU-LEHTINEN, P.; BERGH, J.; SALMINEN, E.; WIKLUND, T.; LEHTINEN, S.; ARONEN, P.; SINTONEN, H. Cost-effectiveness of intensive adjuvant chemotherapy for high-risk breast cancer: Is tailored and dose-escalated chemotherapy with growth factor support (GFS) more costly and less effective than marrow-supported high-dose chemotherapy – results from a ra. Acta Oncologica, [S. l.], v. 46, n. 2, p. 146–152, 2007. DOI: 10.1080/02841860600965012. Disponível em: https://medicaljournalssweden.se/actaoncologica/article/view/26218. Acesso em: 17 may. 2026.